Dr. Carole Samango-Sprouse, Ed.D. APIB, BNABS, NDT Certified Neurodevelopmentalist Dr. Carole Samango-Sprouse has been working with young disabled children since 1982. She received her doctorate from George Washington University in 1987 where she specialized in neurodevelopmental assessment of children with complex medical conditions. Dr. Samango-Sprouse has very eclectic training. She is trained in neuromotor and neurocognitive development, neurobehavioral skills and oral motor assessment for children with an emphasis on young children with genetic disorders. She is certified in neurodevelopmental training (NDT), assessment of pre-term infant behavior (APIB) and the Brazelton Neonatal Assessment Scale (BNABS). Dr. Samango-Sprouse studied with the renowned Dr. Heidilaise ALS at Harvard University at Children’s Hospital of Boston in neurobehavioral assessment. She has authored more than fifty articles on the neurocognitive capabilities of atypical children. She studies the relationship between the brain, and behavior and its impact on school performance in children with neurogenetic disorders including N eurofibromatosis-Type1 (NF-1), Sex Chromosome Variations (SCV), Autism Spectrum Disorder and Developmental Dyspraxia among others. Presently, Dr. Samango-Sprouse is the Director of the Neurodevelopmental Diagnostic Center for Young Children in Davidsonville, Maryland and an Associate Clinical Professor of Pediatrics at George Washington University and on Medical staff at Children’s National Medical Center. She evaluates patients with complex diseases such as Autism Spectrum Disorder and Sex Chromosome Variations from all over the world in order to develop comprehensive and intensive intervention programs that are syndrome-specific. These programs recognize the complex interaction and intimate connection between brain, cognition, behavior, learning and medical diagnosis. Dr. Samango-Sprouse believes that a family centered approach is necessary for the child with disabilities in order to optimize intellectual growth and develop appropriate intervention strategies in the home, the school or the community. Parents must be empowered with knowledge regarding the medical condition of their child, how the condition affects learning, the intellectual performance and the educational program. With these skills, parents can advocate for a syndrome-specific educational program in order to optimize the child’s development. She has served on numerous advocacy foundations and Boards of Directors for various health and professional organizations throughout her career. She presently serves on the Board of Directors for the Autism Genetic Resource Exchange (AGRE), which is part of Cure Autism Now, a parent advocacy group that fosters neurobiological research on children with Autism. AGRE is the largest genetic repository of DNA material of families with children who have Autism in the world. She has been on the Scientific Advisory Committee of Klinefelter Syndrome and Associates since 1997. She has trained pediatric residents in the behavioral phenotypes and neurodevelopmental performance of children with various genetic disorders at Children’s National Medical Center in Washington, DC since 1982. She conducts various workshops for educational and ancillary health professionals in optimizing children’s development through the recognition of the relationship between behavior, brain and performance throughout the country and in Denmark.